Shopping cart ITEMS
 modern scholarly publishers in the finest tradition
Login Register
Home
Books
Journals
References
A-Z Index
Author Index
For Our Authors
User Area
Shopping Cart
Contact
Electronic Data Center

Critical Reviews™ in Therapeutic Drug Carrier Systems

 

ISSN for PRINT: 0743-4863

Institutional price:

$1014.00

Issues per year:

6

For Online Access

Best Paper Award Selection - Editorial Board Site

Add subscription to shopping cart

2005, Volume22

Issue 3

  125 pages  

DOI: 10.1615/CritRevTherDrugCarrierSyst.v22.i3   

click 'Save as...' here to save XML metadata

Issue price - $161.00  

Add to shopping cart

  • Advances in Buccal Drug Delivery
  • Raj Birudaraj
    TJL School of Pharmacy and Health Sciences, University of the Pacific, Stockton, California, USA. Current address: Roche Palo Alto, Palo Alto, California, USA

    Ravichandran Mahalingam
    TJL School of Pharmacy and Health Sciences, University of the Pacific, Stockton, California, USA

    Xiaoling Li
    Thomas J. Long School of Pharmacy and Health Sciences, University of the Pacific, Stockton, CA 95211

    Bhaskara R. Jasti
    Thomas J. Long School of Pharmacy and Health Sciences, University of the Pacific, Stockton, CA 95211


    ABSTRACT

    The buccal route offers an attractive alternative for systemic drug delivery of drugs because of better patient compliance, ease of dosage form removal in emergencies, robustness, and good accessibility. Use of buccal mucosa for drug absorption was first attempted by Sobrero in 1847, and since then much research was done to deliver drugs through this route. Today, research is more focused on the development of suitable delivery devices, permeation enhancement, and buccal delivery of drugs that undergo a first-pass effect, such as cardiovascular drugs, analgesics, and peptides. In addition, studies have been conducted on the development of controlled or slow release delivery systems for systemic and local therapy of diseases in the oral cavity. In this review, the anatomy and physiology of buccal mucosa, followed by discussion of recent literature on the buccal permeation enhancement, and pathways of enhancement for various molecules are detailed. In addition, bioadhesion theories from historic perspective and current status are discussed. The various dosage forms on the market and in different stages of development are also reviewed.

    DOI: 10.1615/CritRevTherDrugCarrierSyst.v22.i3.20

    Download article, 295-330 pages

    Article price - $50.00  

    Add to shopping cart

    << Previous article  

    Designed by offsiteteam Designed by offsiteteam Designed by offsiteteam
    Begell House Inc.
    50 Cross Highway,
    Redding, CT 06896
    TEL (203) 938 1300
    FAX (203) 938 1304
    orders@begellhouse.com